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AbsTrACT
Objective The epidemic of obesity is contributing 
to the increasing prevalence of people at high risk of 
cardiovascular disease (cVD), negating the medical 
advances in reducing cVD mortality. We compared 
the clinical and cost- effectiveness of an intensive 
lifestyle intervention consisting of enhanced 
motivational interviewing in reducing weight and 
increasing physical activity for patients at high risk 
of cVD.
Methods a three- arm, single- blind, parallel- 
group randomised controlled trial was conducted in 
consenting primary care centres in south london. We 
recruited patients aged 40–74 years with a Qrisk2 
score ≥20.0%, which indicates the probability 
of having a cVD event in the next 10 years. The 
intervention was enhanced motivational interviewing 
which included additional behaviour change 
techniques and was delivered by health trainers in 
10 sessions over 1 year, in either group (n=697) or 
individual (n=523) format. The third arm received 
usual care (Uc; n=522). The primary outcomes were 
physical activity (mean steps/day) and weight (kg). 
secondary outcomes were changes in low- density 
lipoprotein cholesterol and cVD risk score. We 
estimated the relative cost- effectiveness of each 
intervention.
results at 24 months, the group and individual 
interventions were not more effective than Uc in 
increasing physical activity (mean difference=70.05 
steps, 95% ci −288.00 to 147.90 and mean 
difference=7.24 steps, 95% ci −224.01 to 
238.50, respectively), reducing weight (mean 
difference=−0.03 kg, 95% ci −0.49 to 0.44 and 
mean difference=−0.42 kg, 95% ci −0.93 to 0.09, 
respectively) or improving any secondary outcomes. 
The group and individual interventions were not cost- 
effective at conventional thresholds.
Conclusions enhancing motivational interviewing 
with additional behaviour change techniques was not 
effective in reducing weight or increasing physical activity 
in those at high cVD risk.
InTrOduCTIOn
Cardiovascular disease (CVD) remains the leading 
cause of mortality.1 Reduction in levels of physical 
activity and rising levels of obesity are limiting the 
decline in CVD mortality.2 The most effective inter-
ventions for primary prevention of CVD in high- 
risk individuals remain unclear. Walking, especially 
with a pedometer, is promoted as a near- perfect 
exercise,3 4 but this has not been studied in high- 
risk CVD populations. Lowering fat and increasing 
fibre, fruit and vegetable intake do reduce the risk 
for CVD in the short- term,5 but evidence of long- 
term benefits is needed.
Psychological processes are important in initiating 
and maintaining change to healthier lifestyles. One 
approach is to use motivational interviewing, which 
is a collaborative, goal‐oriented behaviour change 
technique that encourages the language of change.6 
The appeal of motivational interviewing is that it is 
brief, has a validated competency framework and 
can be enhanced by other behaviour change tech-
niques (eg, goal- setting, self- monitoring and social 
support).7 8 The small number of studies assessing 
the effectiveness of motivational interviewing in 
reducing CVD risk have produced mixed results.9
The primary aim was to compare the effective-
ness and cost- effectiveness of enhanced motiva-
tional interviewing delivered by health trainers 
in increasing physical activity, reducing weight in 
people at high risk of CVD over 24 months was 
greater in those who received it in a group format 
compared with individual format or with usual care 
(UC).
MeThOds
Trial design
This was a three- arm, parallel- group randomised 
controlled trial (RCT), called MOVE IT (MOtiVa-
tional intErviewing InTervention), for individuals at 
high risk for CVD using a partially clustered design 
followed- up at 12 and 24 months from baseline. 
The three arms were: enhanced motivational inter-
viewing in a group format, enhanced motivational 
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interviewing in an individual format and UC. As participants 
of the group arm, but not the other two arms, were clustered 
within groups, we had a partially clustered design. The protocol 
is published online.10
setting
General practices with list sizes >5000 patients in 12 south 
London boroughs (Bexley, Bromley, Croydon, Greenwich, 
Kingston, Lambeth, Lewisham, Merton, Richmond, Southwark, 
Sutton and Wandsworth) representing a varied urban, socio-
economic and ethnically diverse population of approximately 3 
million.11
Participants
Potentially eligible participants were identified from patient 
record databases and invited for screening. The inclusion criteria 
were: aged ≥40 and ≤74 years; CVD 10- year risk score of 
≥20.0% calculated using QRisk2 (QResearch, Nottingham, 
UK), which is a validated predictive tool for identifying the 
percentage risk of having a fatal or non- fatal cardiovascular 
event in the next 10 years12; fluent in conversational English; 
and permanent UK residence.
The exclusion criteria were: medical diagnosis of CVD; 
having a pacemaker; diabetes, kidney disease, atrial fibril-
lation or stroke; chronic obstructive pulmonary disease; 
disabling neurological disorder; severe mental illness; regis-
tered blind; housebound or resident in nursing home; unable 
to move about independently; more than three falls in past 
year; pregnancy; advanced cancer; morbid obesity (body 
mass index (BMI) >50 kg/m2); participating in a weight loss 
programme or another participant, already randomised, in 
the same household.
randomisation and masking
Simple randomisation of participants was conducted by an 
independent Clinical Trials Unit (King’s College London) using 
computer- generated randomisation blocks. In each block, 10 
subjects were randomised to group, individual or UC arms in a 
4:3:3 ratio. The unequal allocation ratio ensured that the group 
arm had approximately 33% more patients to compensate for 
the loss of power from any clustering effect.
baseline measures
We collected sociodemographic factors, such as age, gender, 
self- report ethnicity, occupational status, educational attain-
ment and marital status. Biomedical data included weight 
(measured in light clothing, without shoes on the class 3 
Tanita SC240 digital scale), height (measured to 0.1), BMI 
(kg/m²), waist and hip circumferences (cm), blood pressure 
(BP, mm Hg), glycated haemoglobin and fasting lipids. Life-
style data collected were alcohol intake (Alcohol Use Disor-
ders Identification Test (AUDIT)),13 smoking status and 
physical activity (ActiGraph GT3X accelerometer, a vali-
dated tri- axial movement sensor).14 Self- reported depressive 
symptoms were collected with the Patient Health Question-
naire 9- item (PHQ-9).15 Participants’ postcodes were used 
to calculate the English Index of Multiple Deprivation 2015 
score.16
usual care
For UC, this consisted of referrals to locally commissioned 
community- based weight loss, smoking cessation and/or exercise 
programmes.
Intervention
The theoretical framework for enhanced motivational inter-
viewing was based on social cognitive theory, and the theory of 
planned behaviour which states that to change behaviour, people 
need to form an intention (cognition).17 18 Intention formation is 
influenced by: i) expected value or positive attitude; ii) subjective 
norm and iii) self- efficacy.
The intervention was manualised and consisted of 10 sessions 
over 12 months delivered by health trainers. Participants 
received a workbook, key learning points for every session, 
action planning worksheets, case studies, self- monitoring diaries 
and a pedometer with instructions on its use. The intensive phase 
consisted of 6 weekly sessions during the first 3 months focused 
on physical activity and diet. The maintenance phase consisted 
of four sessions delivered at 3, 6, 9 and 12 months.
The training consisted of 8 weeks of didactic learning, 
role- playing, group exercises and case discussions using 
standardised materials on motivational interviewing 
and behaviour change techniques drawn from cognitive 
behaviour therapy. Each health trainer’s competency was 
assessed at the end of training via a knowledge test and 
through observing delivery of two sessions.10 As additional 
quality assurance, all sessions were audiotaped and compe-
tency was monitored and supervised weekly by the clinical 
psychologist. Fidelity to the manual consisted of the health 
trainer recording targets set and achieved per session. In 
the group intervention, lasting 120 min, patients were addi-
tionally encouraged to use peer support during and between 
sessions. Those randomised to the individual arm received 
the same intervention, but without peer support, in sessions 
lasting 40 min.
Outcomes
The primary outcomes were physical activity (average number 
of steps/day) and weight (kg) and the secondary outcomes were 
low- density lipoprotein (LDL) cholesterol and QRisk2 score, 
measured at 12- month and 24- month follow- ups and adjusted 
for baseline values.
economic outcomes
The EQ- 5D- 3L was used to generate quality- adjusted life 
years (QALY). Intervention costs were calculated taking into 
account staff time delivering the sessions and the unit costs 
included overheads and on- costs and accounted for the ratio 
of direct- to- indirect contact time. We assumed the unit cost/
hour of a National Health Service band 3 clinician at £32.40. 
For the group intervention, the costs were apportioned over 
attendees. Other service costs were measured by combining 
service use data from the Client Service Receipt Inventory 
with unit costs.19 20
statistical analysis
The primary analyses were aligned with Consolidated Standards 
for Reporting Trials. Baseline characteristics of those who did 
and did not provide follow- up data was described.
Analyses based on an intention- to- treat principle using all 
available outcome data were used to estimate the differences 
12 and 24 months using mixed- effects adjusted for the base-
line value of the outcome. In the linear mixed model ‘treatment 
arm’, ‘time’ (a categorical variable with two levels: 12 and 24 
months), the ‘interaction between treatment arm and time’, 
‘borough’, ‘ethnicity’, ‘age’, ‘gender’ and the ‘baseline values’ of 
the outcome variable were fixed factors.
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The random parts of the models were ‘GP practice’ (patients 
are nested in practices) and ‘therapy group’. The study’s design 
was complex as it is partially clustered and cross- classified. In 
the preliminary analyses with blinded data, the model did not 
converge, therefore we removed the random effect for thera-
pist from the analysis. In order to model the dependency of the 
repeated observations of the same subjects at 12 and 24 months, 
we model the covariance between the residuals within the lowest 
level group ‘patients’ to be correlated by using an unstructured 
covariance pattern model.
A two- tailed α of 2.5% for the two main comparisons ‘group 
versus UC’ and ‘individual versus UC’ was used and 97.5% CIs 
are presented. All secondary hypotheses were assessed on a 5% 
α level with 95% CIs.
Our analysis model assumes that data are missing at random 
with conditions for variables predictive of missingness. We 
compared baseline characteristics of those with and without 
complete physical activity and weight follow- up data. Models 
were rerun with predictors related to outcome missingness 
included as further covariates. Fourteen sensitivity analyses 
adjusting for the influence of missing data, protocol violations 
and potential model misspecifications were conducted for the 
primary outcomes. Group comparison of skewed data were 
performed using the median test. STATA V.14 was used for the 
primary and secondary analyses.
Cost-effectiveness analysis
We used bootstrapping methods to estimate 95% CIs around 
the mean cost differences. QALYs were calculated from the 
EQ- 5D- 3L. Area under the curve methods calculated the 
QALY gain over the follow- up period and QALY differences 
were analysed controlling for baseline EQ- 5D- 3L score. If 
costs were higher for one arm compared with another and 
QALY gains were greater, we constructed an incremental 
cost- effectiveness ratio (ICER) to show the cost per extra 
QALY gained. Uncertainty around cost and QALY estimates 
was explored using cost- effectiveness planes generated 
from 1000 bootstrapped resamples. Finally, we gener-
ated cost- effectiveness acceptability curves, using the net- 
benefit approach and bootstrapping, to assess which of the 
three approaches was the most cost- effective. The range of 
values used was £0–£100 000, including the guidance- based 
threshold of £20 000–£30 000.21 Sensitivity analyses were 
conducted around key costs.
sample size
We selected a conservative difference of 0.25 pooled SD 
in the main outcomes, which translates to a mean clinical 
difference (MCD) between two groups of 675 steps/day, 
1.25 kg and 0.25 mmol/L total cholesterol.22 We assumed an 
intraclass correlation coefficient of 0.05. To detect differ-
ences in our primary outcomes at a two- tailed α of 0.025 
and accounting for the comparisons of ‘group versus UC’ 
and ‘individual versus UC’, 1420 participants were required. 
Assuming approximately 17% loss to follow- up, a final 
sample of 1704 patients was required.
Protocol violation
On 18 October 2016, a university- wide IT network outage 
occurred leading to loss of 95 24 months accelerometer data 
files and 2651 audiotaped intervention sessions. We repeated 
the accelerometer data for 87 (91.6%) participants and retrieved 
395 (14.9%) sessions from other computer drives.
role of the funding source
The funder of the study had no role in study design, data collec-
tion, analysis, interpretation or manuscript preparation. The 
corresponding author had full access to all the data and final 
responsibility for submitting for publication.
resulTs
Of the 455 general practices invited, 135 (29.7%) consented; 
there was no difference in the general practices which did and 
did not consent.11 Participants were recruited between June 
2013 and February 2015. Figure 1 shows the participant flow 
through the study. Participants were predominantly older, male 
and of white ethnicity; there was no significant imbalance in 
the baseline characteristics between arms (table 1). At baseline, 
participants took an average of 6757.63 (2716.55) steps/day and 
weighed 83.60 (15.06) kg.
Intervention delivery and receipt
Overall, 1220 participants were randomised to either the group 
or individual intervention; 28.2% did not start the intervention, 
17.3% started but did not complete the intervention and 54.5% 
completed the intervention. The three most common reasons 
for participants not starting or completing the intervention were 
being too busy (27.4%), unable to contact (16.0%) or no longer 
interested in participating (15.5%). Participants in the individual 
arm attended more sessions (median=10, IQR=7–10) than 
those in the group arm (median=7, IQR=5–9; p<0.001). The 
online supplementary material provides further details of inter-
vention delivery.
Fidelity to the manual was high, with the majority of 
participants setting targets at each session (91.6%) and the 
majority of these targets were achieved (90.9% achieved 
fully or partially; online supplementary table S3). The health 
trainers remained generally proficient (online supplemen-
tary material).
loss to follow-up
The loss to follow- up for both primary outcomes at 24 
months was 18.4%, 19.7% and 11.9% for the group, indi-
vidual and UC arms, respectively. The differences in loss to 
follow- up between the treatment arms were significant at 
24 months follow- up (χ2(2)=13.39, p=0.001). Data were 
collected for 91.6% of participants for at least one of the 
12- month or 24- month follow- ups, and for 79.7% of partic-
ipants at both follow- ups. Participants missing 24- month 
outcome data walked significantly less at baseline (6376.9 
(2497.2) vs 6833.1 (2752.5) steps per day, t=−2.78, 
p=0.006), were more likely to be current smokers (22.0% 
vs 14.4%, χ2(2)=6.4, p=0.041), to have no formal qualifi-
cations (33.2% vs 23.8%, χ2(2)=12.3, p=0.002) and to be 
more depressed (PHQ-9 score of 2.47 (3.87) vs 1.89 (3.05), 
t=2.44, p=0.015). There were no other baseline differences 
between participants with missing data compared with those 
with data. Online supplementary table S4 provides a break-
down of reasons for loss to follow- up.
Primary outcomes
Figures 2 and 3 summarise physical activity and weight, 
respectively, at each time point and include the pairwise 
comparison output. For physical activity, we did not observe 
any differences between the group or individual arms and 
UC at 12 or 24 months. For weight at 12 months, the group 
and individual arms had slight but significant reductions 
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Figure 1 Study flow diagram. BMI, body mass index; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HbA1c, glycated 
haemoglobin; PA. physical activity.
compared with UC, however, there were no differences at 24 
months. All group differences (including limits of the 97.5% 
CIs) for physical activity and weight were below the MCD 
of 675 steps or 1.25 kg, respectively. Online supplementary 
tables S7- S8 present the fixed and random effects of the 
mixed- effects regression analysis on the primary outcomes. 
None of the sensitivity analyses altered our conclusions for 
either of the primary outcomes.
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Table 1 Baseline characteristics of participants by trial arm
Trial arm
Total (n=1742)
Group 
(n=697)
Individual 
(n=523) uC (n=522)
Age, mean (SD) 69.59 (4.16) 69.76 (4.11) 69.96 (4.05) 69.75 (4.11)
Gender, n (%)
  Male 593 (85.1) 457 (87.4) 440 (84.3) 1490 (85.5)
  Female 104 (14.9) 66 (12.6) 82 (15.7) 252 (14.5)
Ethnicity, n (%)
  White 614 (88.1) 471 (90.1) 473 (90.6) 1558 (89.4)
  Asian 75 (10.8) 45 (8.6) 41 (7.9) 161 (9.2)
  African/Caribbean 8 (1.1) 7 (1.3) 8 (1.5) 23 (1.3)
Current employment, n (%)
  Yes 166 (23.8) 114 (21.8) 99 (19.0) 379 (21.8)
  No 531 (76.2) 409 (78.2) 423 (81.0) 1363 (78.2)
Qualification, n (%)
  No formal qualifications 186 (27.2) 126 (24.4) 122 (23.8) 434 (25.3)
  GCSE or equivalent 188 (27.4) 141 (27.3) 143 (27.9) 472 (27.6)
  A Level or higher 311 (45.4) 249 (48.3) 247 (48.2) 807 (47.1)
Relationship status, n (%)
  Married/Cohabiting 521 (74.7) 412 (78.8) 371 (71.1) 1304 (74.9)
  Divorced/Separated/
Widowed
100 (14.3) 62 (11.9) 82 (15.7) 244 (14.0)
  Single 76 (10.9) 49 (9.4) 69 (13.2) 194 (11.1)
IMD 2015 quintile, n (%)
  First (most deprived) 63 (9.1) 46 (8.8) 52 (10.0) 161 (9.3)
  Second 122 (17.6) 125 (23.9) 108 (20.7) 355 (20.4)
  Third 136 (19.6) 88 (16.9) 93 (17.8) 317 (18.2)
  Fourth 166 (23.9) 116 (22.2) 124 (23.8) 406 (23.3)
  Fifth (least deprived) 208 (29.9) 147 (28.2) 145 (27.8) 500 (28.8)
Smoking status, n (%)
  Current smoker 112 (16.1) 75 (14.3) 81 (15.5) 268 (15.4)
  Ex- smoker 380 (54.5) 315 (60.2) 290 (55.6) 985 (56.5)
  Non- smoker 205 (29.4) 133 (25.4) 151 (28.9) 489 (28.1)
Number of cigarettes per day 
if current smoker, mean (SD)
11.6 (8.4) 11.0 (8.1) 11.2 (9.2) 12.7 (10.9)
Alcohol intake (AUDIT score), 
n (%)
  Abstainer (0) 73 (10.5) 54 (10.3) 55 (10.5) 182 (10.4)
  Low risk (1-7) 506 (72.6) 397 (75.9) 383 (73.4) 1286 (73.8)
  Possibly harmful (≥8) 118 (16.9) 72 (13.8) 84 (16.1) 274 (15.7)
Depressive symptoms (PHQ-
9 score), mean (SD)
2.07 (3.38) 1.98 (3.05) 1.88 (3.13) 1.99 (3.21)
AUDIT, Alcohol Use Disorders Identification Test; GCSE, General Certificate of Secondary Education; 
IMD, Index of Multiple Deprivation; PHQ-9, Patient Health Questionnaire 9- item.
Figure 2 Summary of physical activity (steps) outcome by trial arm. 
PA, physical activity; UC, usual care.
Figure 3 Summary of weight (kg) outcome by trial arm. UC, usual 
care.
secondary outcomes
We did not observe any treatment effects for the secondary 
outcomes at 12 or 24 months (table 2).
Cost-effectiveness
Service costs (including zero costs for non- users) were similar 
for inpatient care, outpatient attendances and community 
contacts were similar between arms (online supplementary table 
S15). The intervention cost was highest for those in the indi-
vidual arm. After controlling for baseline costs, total costs did 
not differ between the three arms. Mean EQ- 5D tariff scores 
were similar for each arm and did not change markedly over 
time (online supplementary table S16). Controlling for baseline 
utility, QALYs did not differ between the three arms.
The group arm was less effective than UC and more 
expensive; as such it was dominated. Individual was more 
expensive and more effective. The ICER was £55 313 per 
QALY (£354 divided by 0.0064 QALYs). The ICER of the 
individual arm compared with the group arm was £8287 per 
QALY (£179 divided by 0.0216 QALYs) (online supplemen-
tary figures S2- S3). At a value of £30 000, the individual, 
group and UC arms had a 38.1%, 3.2% and 58.7% likeli-
hood of being the most cost- effective option, respectively. 
The results of the sensitivity analyses did not alter the above 
results (online supplementary material).
Adverse events
Five hundred twenty- three adverse events (AEs) were 
reported between baseline and 24- month follow- up. There 
were no differences in mean (SD) number of AEs experi-
enced by participants in the group, individual and UC arms 
(0.37 (0.61), 0.33 (0.54) and 0.35 (0.57), respectively, 
(F(2)=0.68, p=0.51)) or in the number of fatal or non- fatal 
cardiovascular events (online supplementary table S17).
dIsCussIOn
summary of the clinical effectiveness of MOVe IT
Enhanced motivational interviewing was not effective or cost- 
effective in improving physical activity, weight, LDL cholesterol 
or QRisk2 scores in adults at high risk of CVD over 24 months 
compared with UC.
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Table 2 Descriptive summary of secondary outcomes by trial arm and time and pairwise comparison output
Time
Trial arm Pairwise comparisons
Group Individual uC Group–uC Individual–uC Individual–group
LDL cholesterol 
(mmol/mol)
Baseline 3.11 (0.85) 3.14 (0.89) 3.07 (0.88)
12 months 2.93 (0.85) 2.92 (0.83) 2.91 (0.87) 0 (−0.07 to 0.07) 0 (−0.07 to 0.08) 0 (−0.07 to 0.08)
24 months 3.04 (0.90) 3.02 (0.88) 2.94 (0.90) 0.07 (−0.01 to 0.15) 0.05 (−0.04 to 0.14) −0.02 (−0.10 to 0.07)
QRisk2 score
(%)
Baseline 24.95 (4.79) 25.26 (5.27) 24.93 (4.81)
12 months 25.18 (5.60) 25.54 (5.93) 25.50 (6.04) −0.28 (−0.79 to 0.23) −0.14 (−0.68 to 0.40) 0.14 (−0.36 to 0.64)
24 months 26.73 (7.12) 27.04 (6.59) 26.69 (6.76) 0.01 (−0.68 to 0.71) 0.05 (−0.63 to 0.72) 0.03 (−0.64 to 0.71)
Cell values are mean (SD) or estimate (95% CI).
LDL, low- density lipoprotein; UC, usual care.
Key messages
What is already known on this subject?
 ► Although mortality from cardiovascular disease (CVD) is 
falling, the epidemic of obesity and unhealthy lifestyles is 
increasing the risk of CVD.
 ► There is little evidence as to whether a primarily 
psychological approach that aims to change a person’s 
intentions (cognitions) can alter lifestyle behaviour.
What might this study add?
 ► This study was a response to a National Institute of Health 
Research commissioned brief to test whether enhanced 
motivational interviewing (a low- intensity psychological 
intervention combining motivational interviewing with 
additional behaviour change techniques) delivered by health 
trainers could improve lifestyles and thus reduce CVD risk.
 ► We found that enhanced motivational interviewing did not 
lead to a reduction in weight or increase in physical activity 
compared with usual care.
how might this impact on clinical practice?
 ► We conclude that enhanced motivational interviewing have 
little impact for reducing CVD risk in people at high CVD risk 
when applied to the general population.
 ► This raises the question as to whether the administration of 
low intensity psychological techniques in lifestyle- related 
interventions are of any clinical benefit.
strengths and limitations
This RCT was powered to detect small effect sizes in a real- world 
setting. We developed a standardised health trainer manual for 
replicability. We used accelerometers as the gold standard for 
objectively measuring physical activity.
The QRisk2 had a high false- positive rate (figure 1) because 
the medical records required for its algorithm were not always 
accurate resulting in high levels of ineligibility. Our sample 
may not have represented all those at higher CVD risk as the 
average QRisk2 score was at the lower end.23 We also found 
that boroughs with higher levels of socioeconomic deprivation 
and greater ethnic diversity had less uptake.11 Logistical barriers 
led to supply lag of some health trainers, which contributed to 
longer waiting time than desired and may explain some of the 
reduced uptake of the interventions. Attrition from psycholog-
ical interventions is a common phenomenon,24 perhaps more in 
those allocated to groups which may induce social avoidance in 
some participants. Loss to follow- up was unusually lower in UC 
compared with the intervention arms; we have speculated that 
study fatigue may have contributed.
Interpretation
One explanation for the negative finding is that our sample was 
skewed to non- modifiable risk factors in the QRisk2 algorithm 
(age, gender and ethnicity), and on average not obese with a 
lower than expected CVD risk score.25 Furthermore, partici-
pants had average and possibly optimum baseline step in line 
with healthy older adults.4 26 It may have been more appropriate 
to recruit by raised BMI, blood pressure and LDL cholesterol, 
which are modifiable risk factors,9 or selected a higher QRisk2 
score.
A second potential explanation is that the intervention 
potency was subtherapeutic. For this clinical group, namely 
patients with a high CVD risk but with few psychological or 
physical symptomatic distress, the motivational interviewing 
approach is inappropriate. For example, the prevalence for 
significant depressive symptoms was very low (1.4%), lower 
than the general population.
Landmark studies have repeatedly shown that intensive life-
style instruction, such as the diabetes prevention studies27 
and weight reduction programmes,28 do lead to significantly 
improved outcomes. In these interventions, the clinically active 
ingredients included intensive, highly structured, prescribed 
dietary and/or physical activity programmes following a coun-
selling approach and greater emphasis on formal social support, 
information giving and monitoring of weight and exercise. Our 
intervention did not prescribe a dietary or physical activity 
programme but aimed to address cognitions that resisted dietary 
and/or physical activity changes and to increase an individual’s 
intentions to change.
research implications and future directions
First, this intervention might have been more successful in those 
with modifiable CVD risk factors rather than the QRisk2 score 
alone and if we had much shorter waiting lists. The potential of 
an enhanced motivational interviewing approach to a younger 
population, those living in deprived areas and of non- white 
ethnicity remains unknown. We used the same strategies for 
recruitment regardless of socioeconomic, ethnicity and inner 
city status and future studies could instead oversample in these 
subgroups to recruit those at higher CVD risk.
Second, we may need to consider more intensive approaches 
to supporting lifestyle change in those most at risk of CVD. For 
instance, psychological constructs such as optimistic bias and 
habit formation are common patterns.9 29 30 Prioritising public 
health or community interventions that aim to overcome the 
stigma towards obesity and challenging unhelpful beliefs such 
as optimistic bias (“it’s not going to happen to me”) and habit 
formation maybe more effective than individualised approaches.
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summary
An intensive lifestyle intervention using enhanced motivational 
interviewing skills was not associated with reduced weight or 
increased physical activity in people at high risk of CVD. Future 
interventions should focus on those at very high CVD risk and/
or with modifiable risk factors.
Patient and public involvement
The expert- by- experience patient participants (Jennifer Bostock, 
Carole Haynes) contributed to the design, conduct, reporting, 
and dissemination of our research.
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